Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)

Author(s):
Schauwvlieghe, A.M.E.; Dijkman, G.; Hooymans, J.M.; Verbraak, F.D.; Hoyng, C.B.; Dijkgraaf, M.G.W.; Leeuwen, R. van; Vingerling, J.R.; Moll, A.C.; Schlingemann, R.O.
Published
2015
Publication type
Article / Letter to editor
Diabetic retinopathyDiabetic macular edemaVEGFRanibizumabLucentisBevacizumabAvastinRandomized clinical trial
Date issued
2015-07-07
Language
English
Is part of
BMC Ophthalmology
hdl
1887/102746
doi
10.1186/s12886-015-0043-x